Cargando…

Expressed Protein Selenoester Ligation

Herein, we describe the development and application of a novel expressed protein selenoester ligation (EPSL) methodology for the one‐pot semi‐synthesis of modified proteins. EPSL harnesses the rapid kinetics of ligation reactions between modified synthetic selenopeptides and protein aryl selenoester...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Sameer S., Watson, Emma E., Maxwell, Joshua W. C., Niederacher, Gerhard, Johansen‐Leete, Jason, Huhmann, Susanne, Mukherjee, Somnath, Norman, Alexander R., Kriegesmann, Julia, Becker, Christian F. W., Payne, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314092/
https://www.ncbi.nlm.nih.gov/pubmed/35194928
http://dx.doi.org/10.1002/anie.202200163
Descripción
Sumario:Herein, we describe the development and application of a novel expressed protein selenoester ligation (EPSL) methodology for the one‐pot semi‐synthesis of modified proteins. EPSL harnesses the rapid kinetics of ligation reactions between modified synthetic selenopeptides and protein aryl selenoesters (generated from expressed intein fusion precursors) followed by in situ chemoselective deselenization to afford target proteins at concentrations that preclude the use of traditional ligation methods. The utility of the EPSL technology is showcased through the efficient semi‐synthesis of ubiquitinated polypeptides, lipidated analogues of the membrane‐associated GTPase YPT6, and site‐specifically phosphorylated variants of the oligomeric chaperone protein Hsp27 at high dilution.